At the news
? NEUTRALIMPACT 3/10 8-K filed Aug 25, 2026 at 08:15 ET
Septerna appointed Rajiv Patni, M.D., as Chief Medical Officer, effective August 24, 2026. Dr. Patni brings over 25 years of biopharmaceutical experience and a track record of 10 regulatory approvals, which is a positive signal for the company's clinical-stage pipeline execution. This is a routine executive hire for a clinical-stage biotech and does not include any financial data or guidance changes.
- Septerna appointed Rajiv Patni, M.D., as Chief Medical Officer, effective August 24, 2026.
- Dr. Patni has over 25 years of experience and has contributed to 10 regulatory agency approvals or label expansions.
- He most recently served as CEO of Judo Bio and previously as CMO at Global Blood Therapeutics, Portola Pharmaceuticals, and Adamas Pharmaceuticals.
- The filing contains no financial data, guidance, or material business updates.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access